Loading…
Improvement in renal function following cryoballoon ablation for atrial fibrillation
Purpose Patients with chronic kidney disease are predisposed to heart rhythm disorders including atrial fibrillation (AF). Several studies have suggested that radiofrequency catheter ablation of AF improves renal function. However, little data exists for pulmonary vein isolation with cryoballoon abl...
Saved in:
| Published in: | Journal of interventional cardiac electrophysiology 2021-04, Vol.60 (3), p.513-520 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3 |
| container_end_page | 520 |
| container_issue | 3 |
| container_start_page | 513 |
| container_title | Journal of interventional cardiac electrophysiology |
| container_volume | 60 |
| creator | Diaz, Celso L. Kaplan, Rachel M. Peigh, Graham Bavishi, Aakash Baman, Jayson R. Trivedi, Amar Shen, Mark J. Sattayaprasert, Prasongchai Wasserlauf, Jeremiah Arora, Rishi Chicos, Alexandru B. Kim, Susan Lin, Albert Verma, Nishant Knight, Bradley P. Passman, Rod S. |
| description | Purpose
Patients with chronic kidney disease are predisposed to heart rhythm disorders including atrial fibrillation (AF). Several studies have suggested that radiofrequency catheter ablation of AF improves renal function. However, little data exists for pulmonary vein isolation with cryoballoon ablation (CBA). The purpose of this study is to assess change in renal function following CBA for AF.
Method
This is a single-center retrospective study that included patients who underwent CBA for AF between 2011 and 2016. Patients were grouped by baseline-estimated glomerular filtration rate (eGFR): ≥ 90 (Stage G1), 60–89.9 (Stage G2), and 30–59.9 mL/min/1.73 m
2
(Stage G3). Change in eGFR was assessed > 3 months post-ablation.
Results
A total of 306 patients with both pre- and post-ablation serum creatinine measurements available were included. Baseline eGFRs for Stages G1, G2, and G3 patients were 103.5 ± 12.9 (
n
= 82), 74.7 ± 8.2 (
n
= 184), and 52.6 ± 6.6 mL/min/1.73 m
2
(
n
= 40), respectively. Renal function was assessed 310.8 ± 104.2 days post-ablation. Average intra-procedural contrast use was 58.4 ± 23.8 mL. There was no significant change in eGFR following CBA in Stage G1 patients (
p
= 0.10). For those with Stages G2 and G3 renal function, eGFR improved by 6.1% (4.2 mL/min/1.73 m
2
,
p
|
| doi_str_mv | 10.1007/s10840-019-00690-0 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9351706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2529012698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3</originalsourceid><addsrcrecordid>eNp9UU1v3CAURFGrfPYP5BBZ6iUXtw8MNlwiRVGTRorUyx5yQ8DiLZENW7BT5d_3pd6mbQ4RBx7vzQwMQ8gphU8UoPtcKEgONVBVA7QKqz1ySEXHaimUeId1I5taduL-gByV8gAACli7Tw4axqkQgh-S1e24zenRjz5OVYhV9tEMVT9HN4UUqz4NQ_oZ4qZy-SlZgyfsGjuY3ThXZsrhmRJsDsPSPyHvezMU_2G3H5PV9ZfV1df67tvN7dXlXe14x6d6ve49Z0qiAUWBt-2aWat674HaDpvSdox5J4Hzplfecd9RcJxa66EF2xyTi0V2O9vRrx1ayGbQ2xxGk590MkH_P4nhu96kR60aQTtoUeB8J5DTj9mXSY-hOI8uok9z0YwDLimBIfTjK-hDmjP-FaIEU0BZqySi2IJyOZWSff_yGAr6OTO9ZKbRnf6dmQYknf1r44XyJyQENAug4ChufP579xuyvwCNYKOq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2529012698</pqid></control><display><type>article</type><title>Improvement in renal function following cryoballoon ablation for atrial fibrillation</title><source>Springer Nature</source><creator>Diaz, Celso L. ; Kaplan, Rachel M. ; Peigh, Graham ; Bavishi, Aakash ; Baman, Jayson R. ; Trivedi, Amar ; Shen, Mark J. ; Sattayaprasert, Prasongchai ; Wasserlauf, Jeremiah ; Arora, Rishi ; Chicos, Alexandru B. ; Kim, Susan ; Lin, Albert ; Verma, Nishant ; Knight, Bradley P. ; Passman, Rod S.</creator><creatorcontrib>Diaz, Celso L. ; Kaplan, Rachel M. ; Peigh, Graham ; Bavishi, Aakash ; Baman, Jayson R. ; Trivedi, Amar ; Shen, Mark J. ; Sattayaprasert, Prasongchai ; Wasserlauf, Jeremiah ; Arora, Rishi ; Chicos, Alexandru B. ; Kim, Susan ; Lin, Albert ; Verma, Nishant ; Knight, Bradley P. ; Passman, Rod S.</creatorcontrib><description>Purpose
Patients with chronic kidney disease are predisposed to heart rhythm disorders including atrial fibrillation (AF). Several studies have suggested that radiofrequency catheter ablation of AF improves renal function. However, little data exists for pulmonary vein isolation with cryoballoon ablation (CBA). The purpose of this study is to assess change in renal function following CBA for AF.
Method
This is a single-center retrospective study that included patients who underwent CBA for AF between 2011 and 2016. Patients were grouped by baseline-estimated glomerular filtration rate (eGFR): ≥ 90 (Stage G1), 60–89.9 (Stage G2), and 30–59.9 mL/min/1.73 m
2
(Stage G3). Change in eGFR was assessed > 3 months post-ablation.
Results
A total of 306 patients with both pre- and post-ablation serum creatinine measurements available were included. Baseline eGFRs for Stages G1, G2, and G3 patients were 103.5 ± 12.9 (
n
= 82), 74.7 ± 8.2 (
n
= 184), and 52.6 ± 6.6 mL/min/1.73 m
2
(
n
= 40), respectively. Renal function was assessed 310.8 ± 104.2 days post-ablation. Average intra-procedural contrast use was 58.4 ± 23.8 mL. There was no significant change in eGFR following CBA in Stage G1 patients (
p
= 0.10). For those with Stages G2 and G3 renal function, eGFR improved by 6.1% (4.2 mL/min/1.73 m
2
,
p
< 0.01) and 13.8% (7.2 mL/min/1.73 m
2
,
p
< 0.01), respectively. This improvement was seen regardless of the presence or absence of recurrent atrial arrhythmias.
Conclusions
CBA for AF may be associated with an improvement in renal function, particularly among those with a reduced baseline eGFR despite recurrence of atrial arrhythmias and intra-procedural contrast use.</description><identifier>ISSN: 1383-875X</identifier><identifier>EISSN: 1572-8595</identifier><identifier>DOI: 10.1007/s10840-019-00690-0</identifier><identifier>PMID: 32415554</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Ablation ; Cardiac arrhythmia ; Cardiology ; Catheters ; Coronary artery disease ; Creatinine ; Epidermal growth factor receptors ; Fibrillation ; Glomerular filtration rate ; Heart diseases ; Kidney diseases ; Medical instruments ; Medicine ; Medicine & Public Health ; Radio frequency ; Renal function</subject><ispartof>Journal of interventional cardiac electrophysiology, 2021-04, Vol.60 (3), p.513-520</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3</citedby><cites>FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3</cites><orcidid>0000-0001-8718-1534</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32415554$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diaz, Celso L.</creatorcontrib><creatorcontrib>Kaplan, Rachel M.</creatorcontrib><creatorcontrib>Peigh, Graham</creatorcontrib><creatorcontrib>Bavishi, Aakash</creatorcontrib><creatorcontrib>Baman, Jayson R.</creatorcontrib><creatorcontrib>Trivedi, Amar</creatorcontrib><creatorcontrib>Shen, Mark J.</creatorcontrib><creatorcontrib>Sattayaprasert, Prasongchai</creatorcontrib><creatorcontrib>Wasserlauf, Jeremiah</creatorcontrib><creatorcontrib>Arora, Rishi</creatorcontrib><creatorcontrib>Chicos, Alexandru B.</creatorcontrib><creatorcontrib>Kim, Susan</creatorcontrib><creatorcontrib>Lin, Albert</creatorcontrib><creatorcontrib>Verma, Nishant</creatorcontrib><creatorcontrib>Knight, Bradley P.</creatorcontrib><creatorcontrib>Passman, Rod S.</creatorcontrib><title>Improvement in renal function following cryoballoon ablation for atrial fibrillation</title><title>Journal of interventional cardiac electrophysiology</title><addtitle>J Interv Card Electrophysiol</addtitle><addtitle>J Interv Card Electrophysiol</addtitle><description>Purpose
Patients with chronic kidney disease are predisposed to heart rhythm disorders including atrial fibrillation (AF). Several studies have suggested that radiofrequency catheter ablation of AF improves renal function. However, little data exists for pulmonary vein isolation with cryoballoon ablation (CBA). The purpose of this study is to assess change in renal function following CBA for AF.
Method
This is a single-center retrospective study that included patients who underwent CBA for AF between 2011 and 2016. Patients were grouped by baseline-estimated glomerular filtration rate (eGFR): ≥ 90 (Stage G1), 60–89.9 (Stage G2), and 30–59.9 mL/min/1.73 m
2
(Stage G3). Change in eGFR was assessed > 3 months post-ablation.
Results
A total of 306 patients with both pre- and post-ablation serum creatinine measurements available were included. Baseline eGFRs for Stages G1, G2, and G3 patients were 103.5 ± 12.9 (
n
= 82), 74.7 ± 8.2 (
n
= 184), and 52.6 ± 6.6 mL/min/1.73 m
2
(
n
= 40), respectively. Renal function was assessed 310.8 ± 104.2 days post-ablation. Average intra-procedural contrast use was 58.4 ± 23.8 mL. There was no significant change in eGFR following CBA in Stage G1 patients (
p
= 0.10). For those with Stages G2 and G3 renal function, eGFR improved by 6.1% (4.2 mL/min/1.73 m
2
,
p
< 0.01) and 13.8% (7.2 mL/min/1.73 m
2
,
p
< 0.01), respectively. This improvement was seen regardless of the presence or absence of recurrent atrial arrhythmias.
Conclusions
CBA for AF may be associated with an improvement in renal function, particularly among those with a reduced baseline eGFR despite recurrence of atrial arrhythmias and intra-procedural contrast use.</description><subject>Ablation</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Catheters</subject><subject>Coronary artery disease</subject><subject>Creatinine</subject><subject>Epidermal growth factor receptors</subject><subject>Fibrillation</subject><subject>Glomerular filtration rate</subject><subject>Heart diseases</subject><subject>Kidney diseases</subject><subject>Medical instruments</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Radio frequency</subject><subject>Renal function</subject><issn>1383-875X</issn><issn>1572-8595</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v3CAURFGrfPYP5BBZ6iUXtw8MNlwiRVGTRorUyx5yQ8DiLZENW7BT5d_3pd6mbQ4RBx7vzQwMQ8gphU8UoPtcKEgONVBVA7QKqz1ySEXHaimUeId1I5taduL-gByV8gAACli7Tw4axqkQgh-S1e24zenRjz5OVYhV9tEMVT9HN4UUqz4NQ_oZ4qZy-SlZgyfsGjuY3ThXZsrhmRJsDsPSPyHvezMU_2G3H5PV9ZfV1df67tvN7dXlXe14x6d6ve49Z0qiAUWBt-2aWat674HaDpvSdox5J4Hzplfecd9RcJxa66EF2xyTi0V2O9vRrx1ayGbQ2xxGk590MkH_P4nhu96kR60aQTtoUeB8J5DTj9mXSY-hOI8uok9z0YwDLimBIfTjK-hDmjP-FaIEU0BZqySi2IJyOZWSff_yGAr6OTO9ZKbRnf6dmQYknf1r44XyJyQENAug4ChufP579xuyvwCNYKOq</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Diaz, Celso L.</creator><creator>Kaplan, Rachel M.</creator><creator>Peigh, Graham</creator><creator>Bavishi, Aakash</creator><creator>Baman, Jayson R.</creator><creator>Trivedi, Amar</creator><creator>Shen, Mark J.</creator><creator>Sattayaprasert, Prasongchai</creator><creator>Wasserlauf, Jeremiah</creator><creator>Arora, Rishi</creator><creator>Chicos, Alexandru B.</creator><creator>Kim, Susan</creator><creator>Lin, Albert</creator><creator>Verma, Nishant</creator><creator>Knight, Bradley P.</creator><creator>Passman, Rod S.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8718-1534</orcidid></search><sort><creationdate>20210401</creationdate><title>Improvement in renal function following cryoballoon ablation for atrial fibrillation</title><author>Diaz, Celso L. ; Kaplan, Rachel M. ; Peigh, Graham ; Bavishi, Aakash ; Baman, Jayson R. ; Trivedi, Amar ; Shen, Mark J. ; Sattayaprasert, Prasongchai ; Wasserlauf, Jeremiah ; Arora, Rishi ; Chicos, Alexandru B. ; Kim, Susan ; Lin, Albert ; Verma, Nishant ; Knight, Bradley P. ; Passman, Rod S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Catheters</topic><topic>Coronary artery disease</topic><topic>Creatinine</topic><topic>Epidermal growth factor receptors</topic><topic>Fibrillation</topic><topic>Glomerular filtration rate</topic><topic>Heart diseases</topic><topic>Kidney diseases</topic><topic>Medical instruments</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Radio frequency</topic><topic>Renal function</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diaz, Celso L.</creatorcontrib><creatorcontrib>Kaplan, Rachel M.</creatorcontrib><creatorcontrib>Peigh, Graham</creatorcontrib><creatorcontrib>Bavishi, Aakash</creatorcontrib><creatorcontrib>Baman, Jayson R.</creatorcontrib><creatorcontrib>Trivedi, Amar</creatorcontrib><creatorcontrib>Shen, Mark J.</creatorcontrib><creatorcontrib>Sattayaprasert, Prasongchai</creatorcontrib><creatorcontrib>Wasserlauf, Jeremiah</creatorcontrib><creatorcontrib>Arora, Rishi</creatorcontrib><creatorcontrib>Chicos, Alexandru B.</creatorcontrib><creatorcontrib>Kim, Susan</creatorcontrib><creatorcontrib>Lin, Albert</creatorcontrib><creatorcontrib>Verma, Nishant</creatorcontrib><creatorcontrib>Knight, Bradley P.</creatorcontrib><creatorcontrib>Passman, Rod S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of interventional cardiac electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diaz, Celso L.</au><au>Kaplan, Rachel M.</au><au>Peigh, Graham</au><au>Bavishi, Aakash</au><au>Baman, Jayson R.</au><au>Trivedi, Amar</au><au>Shen, Mark J.</au><au>Sattayaprasert, Prasongchai</au><au>Wasserlauf, Jeremiah</au><au>Arora, Rishi</au><au>Chicos, Alexandru B.</au><au>Kim, Susan</au><au>Lin, Albert</au><au>Verma, Nishant</au><au>Knight, Bradley P.</au><au>Passman, Rod S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improvement in renal function following cryoballoon ablation for atrial fibrillation</atitle><jtitle>Journal of interventional cardiac electrophysiology</jtitle><stitle>J Interv Card Electrophysiol</stitle><addtitle>J Interv Card Electrophysiol</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>60</volume><issue>3</issue><spage>513</spage><epage>520</epage><pages>513-520</pages><issn>1383-875X</issn><eissn>1572-8595</eissn><abstract>Purpose
Patients with chronic kidney disease are predisposed to heart rhythm disorders including atrial fibrillation (AF). Several studies have suggested that radiofrequency catheter ablation of AF improves renal function. However, little data exists for pulmonary vein isolation with cryoballoon ablation (CBA). The purpose of this study is to assess change in renal function following CBA for AF.
Method
This is a single-center retrospective study that included patients who underwent CBA for AF between 2011 and 2016. Patients were grouped by baseline-estimated glomerular filtration rate (eGFR): ≥ 90 (Stage G1), 60–89.9 (Stage G2), and 30–59.9 mL/min/1.73 m
2
(Stage G3). Change in eGFR was assessed > 3 months post-ablation.
Results
A total of 306 patients with both pre- and post-ablation serum creatinine measurements available were included. Baseline eGFRs for Stages G1, G2, and G3 patients were 103.5 ± 12.9 (
n
= 82), 74.7 ± 8.2 (
n
= 184), and 52.6 ± 6.6 mL/min/1.73 m
2
(
n
= 40), respectively. Renal function was assessed 310.8 ± 104.2 days post-ablation. Average intra-procedural contrast use was 58.4 ± 23.8 mL. There was no significant change in eGFR following CBA in Stage G1 patients (
p
= 0.10). For those with Stages G2 and G3 renal function, eGFR improved by 6.1% (4.2 mL/min/1.73 m
2
,
p
< 0.01) and 13.8% (7.2 mL/min/1.73 m
2
,
p
< 0.01), respectively. This improvement was seen regardless of the presence or absence of recurrent atrial arrhythmias.
Conclusions
CBA for AF may be associated with an improvement in renal function, particularly among those with a reduced baseline eGFR despite recurrence of atrial arrhythmias and intra-procedural contrast use.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32415554</pmid><doi>10.1007/s10840-019-00690-0</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-8718-1534</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1383-875X |
| ispartof | Journal of interventional cardiac electrophysiology, 2021-04, Vol.60 (3), p.513-520 |
| issn | 1383-875X 1572-8595 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9351706 |
| source | Springer Nature |
| subjects | Ablation Cardiac arrhythmia Cardiology Catheters Coronary artery disease Creatinine Epidermal growth factor receptors Fibrillation Glomerular filtration rate Heart diseases Kidney diseases Medical instruments Medicine Medicine & Public Health Radio frequency Renal function |
| title | Improvement in renal function following cryoballoon ablation for atrial fibrillation |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A15%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improvement%20in%20renal%20function%20following%20cryoballoon%20ablation%20for%20atrial%20fibrillation&rft.jtitle=Journal%20of%20interventional%20cardiac%20electrophysiology&rft.au=Diaz,%20Celso%20L.&rft.date=2021-04-01&rft.volume=60&rft.issue=3&rft.spage=513&rft.epage=520&rft.pages=513-520&rft.issn=1383-875X&rft.eissn=1572-8595&rft_id=info:doi/10.1007/s10840-019-00690-0&rft_dat=%3Cproquest_pubme%3E2529012698%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-ddfe4298019910466d2bb9fee01b70198b722ec80443f9ec4e710c41bbe060b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2529012698&rft_id=info:pmid/32415554&rfr_iscdi=true |